A few studies have found that functional serotonin 1A receptor (5-HT1A), serotonin transporter (5-HTT), and brain-derived neurotrophic factor (BDNF) gene polymorphisms affected the rTMS treatment response in MDD groups, although the results were inconsistent31. This evidence concerns the gene HTR1A and major depressive disorder.